Literature DB >> 11386607

Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.

M Christiansen1, C K Høgdall, J R Andersen, B Nørgaard-Pedersen.   

Abstract

Alpha-fetoprotein (AFP) is a tumor marker for hepatomas and germ cell tumors, and the serum concentration has prognostic significance in other diseases. We examined the normal serum concentration of AFP in adults and sources of variation in the immunochemical variation of AFP. The serum concentration of the tumor marker alpha-fetoprotein (S-AFP) was log-normally distributed in 284 adult blood donors. S-AFP increased with age (p < 10(-7)), whereas no gender-related difference was found. Reference intervals (95-interpercentile) were constructed for persons < or =40 years (0.60-9.30 kIU/L) and >40 years (1.40 12.60 kIU/L). The concentration of AFP was significantly, albeit slightly, higher in serum than in plasma, whereas hemolysis, pretreatment with KCl and food intake did not influence S-AFP. S-AFP only changed 6% when measured twice 2 months apart (p=0.04). Three enzyme immunoassays, using three different anti-AFP monoclonal antibodies for detection, were compared and two assays gave S-AFP values significantly higher, 2.8% (p=0.03) and 19.0% (p<10(-4)), than the other assay. Thus, the choice of antibody may influence the result of immunochemical concentration determination. This can be explained by the existence of conformational variants of AFP with different antibody reactivities, and calls for careful standardization of monoclonal antibodies used in assays for AFP. With broad population reference ranges and slight intra-personal variation, the most effective reference range for S-AFP is previous values obtained in the same person.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386607     DOI: 10.1080/003655101300133649

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Sensitive electrochemical immunosensor for matrix metalloproteinase-3 based on single-wall carbon nanotubes.

Authors:  Bernard S Munge; Jacqueline Fisher; Lines N Millord; Colleen E Krause; Richard S Dowd; James F Rusling
Journal:  Analyst       Date:  2010-03-31       Impact factor: 4.616

2.  Dynamics of serum α-fetoprotein in viral hepatitis C without hepatocellular carcinoma.

Authors:  Teodora Isac; Sebastian Isac; Simona Ioanitescu; Enyedi Mihaly; Maria-Daniela Tanasescu; Daniela Gabriela Balan; Adrian Tulin; Laura Iliescu
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

3.  Global stability of plasma proteomes for mass spectrometry-based analyses.

Authors:  Lisa J Zimmerman; Ming Li; Wendell G Yarbrough; Robbert J C Slebos; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2012-02-01       Impact factor: 5.911

4.  Flow injection chemiluminescent immunoassay for carcinoembryonic antigen using boronic immunoaffinity column.

Authors:  Xiaoling Ma; Huihui Li; Min Wu; Chong Sun; Laifa Li; Xiaodi Yang
Journal:  Sensors (Basel)       Date:  2009-12-21       Impact factor: 3.576

5.  Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.

Authors:  Roula Tahtouh; Anne-Sophie Azzi; Nada Alaaeddine; Soulaima Chamat; Hasnaa Bouharoun-Tayoun; Layal Wardi; Issam Raad; Riad Sarkis; Najibe Abou Antoun; George Hilal
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

6.  An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors.

Authors:  Mingming Hu; Hongzhi Guan; Ching C Lau; Keita Terashima; Zimeng Jin; Liying Cui; Yuzhou Wang; Guilin Li; Yong Yao; Yi Guo; Yan Michael Li; Dingrong Zhong; Juan Xiao; Xirun Wan; Xin Lian; Feng Feng; Haitao Ren; Yanhuan Zhao; Xinqi Cheng; Feng Gu
Journal:  Eur J Med Res       Date:  2016-03-12       Impact factor: 2.175

7.  Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.

Authors:  Sangmi Jang; Gwang Hyeon Choi; Won Chang; Eun Sun Jang; Jin-Wook Kim; Sook-Hyang Jeong
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

8.  Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.

Authors:  Ruhan Wang; Jing Li; Dan Xu; Ruiyang Li; Ping Gong
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.